van der Linden Anita, Blokker Britt M, Kap Marcel, Weustink Annick C, Robertus Jan L, Riegman Peter H J, Oosterhuis J Wolter
Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
PLoS One. 2014 Dec 22;9(12):e115675. doi: 10.1371/journal.pone.0115675. eCollection 2014.
Bereaved relatives often refuse to give consent for post-mortem investigation of deceased cancer patients, mainly because of the mutilation due to conventional autopsy (CA). Minimally invasive autopsy (MIA) may be a more acceptable alternative and, if implemented in clinical practice, creates an opportunity to more often obtain post-mortem tissue samples of (recurred) primary tumors and metastases for molecular research. As a measure for tissue quality for molecular studies, we hereby present a feasibility study, comparing the RNA quality of MIA and CA samples, and fresh frozen samples as reference.
Tissue samples of heart, liver and kidney were prospectively collected from 24 MIAs followed by CA, and compared to corresponding archival fresh frozen tissue. After RNA isolation and RT-qPCR, RNA integrity numbers (RIN) and GAPDH expression (six amplicon sizes ranging from 71 to 530 base pairs) were measured. RIN values and GAPDH Cq values were analyzed and compared between all sample groups and post-mortem intervals (PMI).
RIN values in MIA samples were significantly higher than those in CA samples. GAPDH was expressed significantly higher in MIA samples than in CA samples and 530 bp PCR products could be measured in all cases. GAPDH expression was significantly lower in samples with PMI >15 hours. As expected, the samples of the fresh frozen reference standard performed best in all analyses.
MIA samples showed better RNA quality than CA samples, probably due to shorter PMI. Both had lower RNA quality and expression levels than fresh frozen tissue, however, remaining GAPDH RNA was still sufficiently intact. Therefore, other highly expressed genes are most likely also detectable. Gene array analysis should be performed to gain insight into the quality of entire post-mortem genomes. Reducing PMI will further improve the feasibility of demanding molecular research on post-mortem tissues, this is most likely more feasible with MIA than CA.
逝者亲属通常拒绝同意对已故癌症患者进行尸检,主要原因是传统尸检(CA)会造成身体毁损。微创尸检(MIA)可能是一种更易被接受的替代方法,若在临床实践中实施,将创造更多机会获取(复发)原发性肿瘤和转移灶的尸检组织样本用于分子研究。作为分子研究中组织质量的一项衡量指标,我们在此开展一项可行性研究,比较MIA样本、CA样本以及作为对照的新鲜冷冻样本的RNA质量。
前瞻性收集24例先进行MIA后进行CA的心脏、肝脏和肾脏组织样本,并与相应的存档新鲜冷冻组织进行比较。在进行RNA分离和逆转录定量聚合酶链反应(RT-qPCR)后,测量RNA完整性数值(RIN)和甘油醛-3-磷酸脱氢酶(GAPDH)表达水平(6种扩增子大小,范围从71至530碱基对)。分析并比较所有样本组和死后间隔时间(PMI)的RIN值和GAPDH定量值。
MIA样本的RIN值显著高于CA样本。GAPDH在MIA样本中的表达显著高于CA样本,且在所有病例中均能检测到530 bp的PCR产物。PMI>15小时的样本中GAPDH表达显著降低。正如预期,新鲜冷冻参考标准样本在所有分析中表现最佳。
MIA样本的RNA质量优于CA样本,可能是由于PMI较短。然而,二者的RNA质量和表达水平均低于新鲜冷冻组织,但剩余的GAPDH RNA仍足够完整。因此,其他高表达基因很可能也可被检测到。应进行基因阵列分析以深入了解整个尸检基因组的质量。缩短PMI将进一步提高对尸检组织进行复杂分子研究的可行性,这在MIA中比在CA中可能更可行。